Sacrements

This article originally appeared at https://www.researchgate.net/publication/274891934_EHMTI-0136_Medical_cannabis_in_the_treatment_of_treatment-resistant_chronic_cluster_headache_A_retrospective_report A Mosek*, M Dano, Y Fainmesser, Z HybloomFrom 4th European Headache and Migraine Trust International Congress: EHMTIC 2014Copenhagen, Denmark. 18-21 September 2014 Background Treatment-resistant chronic cluster headache is a debilitating disease. Since 2011 we were able to offer cannabis and we hereby report our experience using cannabis in this…

This originally appeared at https://www.frontiersin.org/articles/10.3389/fonc.2021.649555/full Authors: Janet Schloss1,2,3*, Judith Lacey4,5,6, Justin Sinclair4, Amie Steel3, Michael Sughrue7, David Sibbritt3 and Charles Teo7 Background: Cannabis for cancer is very topical and, given the use of illicit cannabis preparations used in this vulnerable population, research investigating standardised, quality-assured medicinal cannabis is critical to inform clinicians and assist patient…

This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/35332345/ Authors: Petr Jirasek  1 , Alexandr Jusku  1 , Vilim Simanek  2 , Jana Frankova  2 , Jan Storch  3 , Jan Vacek  2 PMID: 35332345 DOI: 10.5507/bp.2022.012 Cannabidiol (CBD), a non-psychotropic cannabinoid produced by the genus Cannabis, is a phytoceutical that activates the endocannabinoid system (ECS) through binding to CB1 and CB2 receptors….

This article originally appeared at https://www.truenorthlabs.ch/news/can-medical-cannabis-or-cbd-help-with-perimenopause-and-menopausal-related-issues According to the British Menopause Society, 75% of women are affected by menopausal symptoms – an estimated 1.1 billion worldwide. Until recently, hormone replacement therapy (HRT) was the go-to treatment for menopause, however studies in recent years have shown a steep decline in its use (46% in the USA,…

This article originally appeared at https://www.truenorthlabs.ch/news/does-cannabis-affect-men-and-women-differently-exploring-the-impact-of-hormones The impact of hormones on the effects of cannabis can be complex and often misunderstood. While past studies have indicated that the effects of cannabis are the same for men and women, there is a growing body of evidence to suggest that hormonal fluctuations throughout the month can have…

This article originally appeared at https://www.frontiersin.org/articles/10.3389/fneur.2023.1087011/full#.ZBW4f70oTuM.linkedin Cannabidiol (CBD) has numerous pharmacological targets that initiate anti-inflammatory, antioxidative, and antiepileptic properties. These neuroprotective benefits have generated interest in CBD’s therapeutic potential against the secondary injury cascade from traumatic brain injury (TBI). There are currently no effective broad treatment strategies for combating the damaging mechanisms that follow the…

This article originally appeared at https://www.nature.com/articles/1210641 D9-Tetrahydrocannabinol (THC) is the primary cannabinoid of marijuana and has been shown to either potentiate or inhibit tumor growth, depending on the type of cancer and its pathogenesis. Little is known about the activity of cannabinoids like THC on epidermal growth factor receptor-overexpressing lung cancers, which are often highly…

This article originally appeared at https://www.marijuanamoment.net/medical-marijuana-legalization-linked-to-significant-decrease-in-opioid-related-payments-to-doctors-study-finds/ A new study is linking state-level medical marijuana legalization to reduced opioid payouts to doctors—another datapoint suggesting that patients use cannabis as an alternative to prescription drugs when given legal access. The study from researchers at the University of Florida, University of Southern California and Purdue University identified “a…

This article originally appeared at https://jamanetwork.com/journals/jamaoncology/article-abstract/2799132 Authors Yuhua Bao, PhD1,2; Hao Zhang, PhD1; Eduardo Bruera, MD3; et alRussell Portenoy, MD4,5,6; William E. Rosa, PhD, MBE, APRN7; M. Carrington Reid, MD, PhD8; Hefei Wen, PhD9 JAMA Oncol. 2023;9(2):206-214. doi:10.1001/jamaoncol.2022.5623 Key Points Question  Is medical marijuana legalization associated with opioid-related and pain-related outcomes for adult patients newly diagnosed with cancer and receiving anticancer treatment? Findings  This cross-sectional study of 38 189 patients…

This article originally appeared at https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2107673 Abstract Purpose: Opioid use rates have dropped as North American patients gain access to medical cannabis, indicating a harm reduction role, yet health outcomes remain mostly unexplored. This study presents self-reported medical cannabis use, perceptions of health functioning, and changes in opioid pain medication use in Florida medical cannabis…